Terms: = Brain cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Prognosis
19 results:
1. Biological underpinnings of radiomic magnetic resonance imaging phenotypes for risk stratification in IDH wild-type glioblastoma.
Guan F; Wang Z; Qiu Y; Guo Y; Pei D; Wang M; Xing A; Liu Z; Yu B; Cheng J; Liu X; Ji Y; Yan D; Yan J; Zhang Z
J Transl Med; 2023 Nov; 21(1):841. PubMed ID: 37993907
[TBL] [Abstract] [Full Text] [Related]
2. Suicide Risk Among Individuals Diagnosed With cancer in the US, 2000-2016.
Hu X; Ma J; Jemal A; Zhao J; Nogueira L; Ji X; Yabroff KR; Han X
JAMA Netw Open; 2023 Jan; 6(1):e2251863. PubMed ID: 36662522
[TBL] [Abstract] [Full Text] [Related]
3. Cardiovascular outcomes and mortality after incident ischaemic stroke in patients with a recent cancer history.
Akyea RK; Iyen B; Georgiopoulos G; Kai J; Qureshi N; Ntaios G
Eur J Intern Med; 2023 Mar; 109():50-57. PubMed ID: 36549951
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients.
Shi X; Li H; Xu Y; Nyalali AMK; Li F
Neurol Sci; 2022 Sep; 43(9):5523-5531. PubMed ID: 35606674
[TBL] [Abstract] [Full Text] [Related]
5. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with brain Metastases of Non-Small-Cell Lung cancer Treated with Stereotactic Radiotherapy.
Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
[TBL] [Abstract] [Full Text] [Related]
6. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract] [Full Text] [Related]
7. Treatment and outcomes of patients in the brain Metastases in Breast cancer Network Registry.
Witzel I; Laakmann E; Weide R; Neunhöffer T; Park-Simon TJ; Schmidt M; Fasching PA; Hesse T; Polasik A; Mohrmann S; Würschmidt F; Schem C; Bechtner C; Würstlein R; Fehm T; Möbus V; Burchardi N; Loibl S; Müller V
Eur J Cancer; 2018 Oct; 102():1-9. PubMed ID: 30099223
[TBL] [Abstract] [Full Text] [Related]
8. Survival trends in glioma: Experience at a tertiary care centre.
Bose R; Narang KS; Bhangale D; Kedia R; Sharma V; Jha AN
Neurol India; 2017; 65(6):1295-1301. PubMed ID: 29133704
[TBL] [Abstract] [Full Text] [Related]
9. Impact of radiation therapy and extent of resection for ependymoma in young children: A population-based study.
Snider CA; Yang K; Mack SC; Suh JH; Chao ST; Merchant TE; Murphy ES
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115718
[TBL] [Abstract] [Full Text] [Related]
10. Stereotactic Radiosurgery With or Without Whole-brain Radiation Therapy for Limited brain Metastases: A Secondary Analysis of the North Central cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.
Churilla TM; Ballman KV; Brown PD; Twohy EL; Jaeckle K; Farace E; Cerhan JH; Anderson SK; Carrero XW; Garces YI; Barker FG; Deming R; Dixon JG; Burri SH; Chung C; Ménard C; Stieber VW; Pollock BE; Galanis E; Buckner JC; Asher AL
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1173-1178. PubMed ID: 28939223
[TBL] [Abstract] [Full Text] [Related]
11. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract] [Full Text] [Related]
12. Clinical, imaging, and follow-up observations of patients with anti-GABA
Qiao S; Zhang YX; Zhang BJ; Lu RY; Lai QL; Chen LH; Wu J
Int J Neurosci; 2017 May; 127(5):379-385. PubMed ID: 27066808
[TBL] [Abstract] [Full Text] [Related]
13. BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.
Tabouret E; Bequet C; Denicolaï E; Barrié M; Nanni I; Metellus P; Dufour H; Chinot O; Figarella-Branger D
Eur J Surg Oncol; 2015 Dec; 41(12):1685-90. PubMed ID: 26454767
[TBL] [Abstract] [Full Text] [Related]
14. Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.
Ramkissoon SH; Bi WL; Schumacher SE; Ramkissoon LA; Haidar S; Knoff D; Dubuc A; Brown L; Burns M; Cryan JB; Abedalthagafi M; Kang YJ; Schultz N; Reardon DA; Lee EQ; Rinne ML; Norden AD; Nayak L; Ruland S; Doherty LM; LaFrankie DC; Horvath M; Aizer AA; Russo A; Arvold ND; Claus EB; Al-Mefty O; Johnson MD; Golby AJ; Dunn IF; Chiocca EA; Trippa L; Santagata S; Folkerth RD; Kantoff P; Rollins BJ; Lindeman NI; Wen PY; Ligon AH; Beroukhim R; Alexander BM; Ligon KL
Neuro Oncol; 2015 Oct; 17(10):1344-55. PubMed ID: 25754088
[TBL] [Abstract] [Full Text] [Related]
15. Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis.
Chen WJ; He DS; Tang RX; Ren FH; Chen G
Asian Pac J Cancer Prev; 2015; 16(2):411-20. PubMed ID: 25684464
[TBL] [Abstract] [Full Text] [Related]
16. Statin use and survival following glioblastoma multiforme.
Gaist D; Hallas J; Friis S; Hansen S; Sørensen HT
Cancer Epidemiol; 2014 Dec; 38(6):722-7. PubMed ID: 25455652
[TBL] [Abstract] [Full Text] [Related]
17. Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas.
Sai K; Zhong MG; Wang J; Chen YS; Mou YG; Ke C; Zhang XH; Yang QY; Lin FH; Guo CC; Chen ZH; Zeng J; Lv YC; Li X; Gao WC; Chen ZP
J Neurol Sci; 2014 Aug; 343(1-2):60-5. PubMed ID: 24874252
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic factors and survival in primary adult high grade brainstem astrocytoma: a population based study from 1973-2008.
Dey M; Lin Y; Melkonian S; Lam S
J Clin Neurosci; 2014 Aug; 21(8):1298-303. PubMed ID: 24674698
[TBL] [Abstract] [Full Text] [Related]
19. TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas.
Rorive S; Lopez XM; Maris C; Trepant AL; Sauvage S; Sadeghi N; Roland I; Decaestecker C; Salmon I
Mod Pathol; 2010 Oct; 23(10):1418-28. PubMed ID: 20693981
[TBL] [Abstract] [Full Text] [Related]
